SCHEMBL5498985

SCHEMBL5498985

COc1ccc(CCNCc2ccc3[nH]cc(Cc4ccc(C(N)=O)cc4)c3c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 9/20 0.60
▸ SNCA P37840 2/20 0.54
▸ HDAC3 O15379 1/20 0.52
▸ HDAC4 P56524 1/20 0.52
▸ HDAC1 Q13547 1/20 0.52
▸ HDAC7 Q8WUI4 1/20 0.52
▸ HDAC2 Q92769 1/20 0.52
▸ HDAC10 Q969S8 1/20 0.52
▸ HDAC11 Q96DB2 1/20 0.52
▸ HDAC8 Q9BY41 1/20 0.52
▸ HDAC6 Q9UBN7 1/20 0.52
▸ HDAC9 Q9UKV0 1/20 0.52
▸ HDAC5 Q9UQL6 1/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ POLB P06746 1/20 0.52
▸ MTNR1A P48039 2/20 0.51
▸ MTNR1B P49286 1/20 0.51
▸ OPRM1 P35372 1/20 0.48
▸ OPRD1 P41143 1/20 0.48
▸ OPRK1 P41145 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5495196 0.83 SNCA (0.58) HTR2ASNCAHDAC3HDAC4HDAC1
SCHEMBL5498300 0.82 MPO (0.53) HTR2ASNCAHDAC3HDAC4HDAC1
SCHEMBL5499448 0.82 CYP1A2 (0.45) HTR2ASNCAKMT2AOPRM1OPRD1
SCHEMBL5496225 0.82 CYP1A2 (0.45) HTR2ASNCAHDAC3HDAC4HDAC1
SCHEMBL5493877 0.82 SNCA (0.54) SNCAHDAC3HDAC4HDAC1HDAC7
SCHEMBL5500442 0.81 HTR1D (0.47) SNCAKMT2AOPRM1OPRD1OPRK1
SCHEMBL5498261 0.81 SNCA (0.54) SNCAHDAC1KMT2AOPRM1OPRD1
SCHEMBL5499113 0.81 MAPT (0.53) HTR2ASNCAKMT2APOLB
SCHEMBL5499185 0.80 SNCA (0.54) SNCAKMT2AOPRM1OPRD1OPRK1
SCHEMBL5501366 0.78 HTR1A (0.45) SNCAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751103-A1 4-(5-(AMINOMETHYL)-INDOLE-1-YLMETHYL)-BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS OPIOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OBESITY ELI LILLY AND COMPANY (US) 2007-02-14 — — EP claimed
WO-2005090303-A1 4- (5- (AMINOMETHYL) -INDOLE-1-YLMETHYL) -BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS OPIOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OBESITY ELI LILLY AND COMPANY (US) 2005-09-29 — — WO claimed
EP-1751103-A1 4-(5-(AMINOMETHYL)-INDOLE-1-YLMETHYL)-BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS OPIOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OBESITY ELI LILLY AND COMPANY (US) 2007-02-14 — — EP disclosed
WO-2005090303-A1 4- (5- (AMINOMETHYL) -INDOLE-1-YLMETHYL) -BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS OPIOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OBESITY ELI LILLY AND COMPANY (US) 2005-09-29 — — WO disclosed
Send feedback